Gadoteridol is a macrocyclic nonionic gadolinium-based compound used as a contrast agent for magnetic resonance imaging (MRI). It enhances the visibility of lesions with abnormal vascularity or blood-brain barrier disruption in the brain, spine, and surrounding tissues.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 120066-54-8
Calteridol calcium
pharmaceutical raw material
Gadoteric acid
pharmaceutical raw material
Gadodiamide hydrate
pharmaceutical raw material
Gadobutrol
pharmaceutical raw material
Gadopentetate dimeglumine
pharmaceutical raw material
Manidipine
pharmaceutical raw material
Ixazomib citrate 1,3,2-dioxaborinane
pharmaceutical raw material
Tofogliflozin hydrate
pharmaceutical raw material
2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
DPNNNPAKRZOSMO-UHFFFAOYSA-K
CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3]